SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

PCBL edges higher on getting CCI approval to acquire 100% stake in Aquapharm Chemicals

28 Dec 2023 Evaluate

PCBL is currently trading at Rs. 255.05, up by 0.30 points or 0.12% from its previous closing of Rs. 254.75 on the BSE.

The scrip opened at Rs. 254.80 and has touched a high and low of Rs. 258.40 and Rs. 254.60 respectively. So far 59310 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 283.50 on 05-Dec-2023 and a 52 week low of Rs. 108.05 on 29-Mar-2023.

Last one week high and low of the scrip stood at Rs. 258.75 and Rs. 246.55 respectively. The current market cap of the company is Rs. 9670.59 crore.

The promoters holding in the company stood at 51.41%, while Institutions and Non-Institutions held 16.08% and 32.51% respectively.

Anti-trust regulator Competition Commission of India (CCI) has approved speciality chemicals major PCBL’s proposed acquisition of a 100 per cent stake in Aquapharm Chemicals. The CCI has granted its approval to the deal under the green channel route. Under the green channel route, a transaction that does not raise any risk of an appreciable adverse effect on competition is deemed to be approved on being intimated to the fair-trade regulator. 

The transaction relates to PCBL's proposal to acquire 100 per cent equity share capital of Aquapharm Chemicals from the existing shareholders of the company i.e., (members of Desai Group and Mangwani Group). After the completion of the transaction, Aquapharm Chemicals will be a wholly-owned subsidiary of PCBL.

PCBL is primarily engaged in the business of manufacturing & sale of carbon black and sale of power.

PCBL Chemical Share Price

284.35 4.05 (1.44%)
16-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×